Subscribe To
novartis completes sandoz spinoff
novartis has completed the planned spin-off of its generics and biosimilars business Sandoz , the Swiss...
October 4, 2023, 1:20 am
novartis (nvs) announces positive data on kidney disease drug
novartis' (NVS) phase III study on pipeline candidate iptacopan in patients with IgAN shows superiority...
October 3, 2023, 1:32 pm
novartis positioning is now best-suited for long-term gains and returns after spin-off, says ceo
novartis CEO Vas Narasimhan joins 'Squawk on the Street' to discuss the company's new spin-off Sandoz, ...
October 3, 2023, 12:08 pm
novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off
Vas Narasimhan, CEO at novartis, discusses the company's 100% spin off of Sandoz, its generic and biosi...
October 3, 2023, 11:26 am
Here's why novartis (nvs) is a strong value stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Pre...
October 3, 2023, 11:17 am
Drugmakers sign on to negotiate medicare prices under protest
All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, includin...
October 2, 2023, 1:02 pm
novartis' (nvs) sandoz gets ec nod for tysabri's biosimilar
novartis' (NVS) Sandoz broadens its biosimilar portfolio with Tyruko's approval, a biosimilar of the mu...
September 26, 2023, 1:31 pm
novartis: buy this dividend aristocrat for consistent income
novartis' core EPS payout ratio is poised to come in at around 51% in 2023. The Swiss drugmaker grew at...
September 26, 2023, 7:17 am
novartis (nvs) lutathera meets primary goal in phase iii study
novartis' (NVS) radioligand therapy Lutathera reports statistically significant and clinically meaningf...
September 25, 2023, 1:32 pm
Morgan stanley sees biopharma sector as a 'safe haven'
Morgan Stanley (NYSE:MS) expects the EU biopharma sector to offer a safe haven from weakening growth/higher real yields. “Whilst we continue to favo...
September 25, 2023, 10:01 am
novartis confirms sandoz spin-off for october 4, 2023
novartis on Monday confirmed its plans for a 100% spin-off of the Sandoz business on Oct. 4 after share...
September 25, 2023, 1:22 am
Beigene regains rights for cancer drug after novartis deal termination
BeiGene said on Tuesday it would regain rights to develop and manufacture its cancer drug after a deal termination with ...
September 19, 2023, 6:14 am
novartis' (nvs) shareholders approve sandoz separation
novartis' (NVS) shareholders vote in favor of the 100% spin-off of Sandoz into a new publicly traded st...
September 18, 2023, 1:33 pm
novartis shareholders vote in favour of sandoz spin-off
novartis shareholders on Friday voted in favour of spinning off the Swiss company's generic-drugs busin...
September 15, 2023, 5:34 am
novartis' (nvs) sandoz gets rights for stelara biosimilar
novartis (NVS) announces an agreement with Samsung Bioepis for exclusive rights to commercialize the bi...
September 12, 2023, 1:35 pm
Nvs vs. lly: which stock is the better value option?
Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with novartis (NVS) and El...
September 12, 2023, 12:50 pm
Uk's syncona writes off 54.5 mln stg after novartis ends gyroscope's therapy
British healthcare investment firm Syncona said on Monday novartis has stopped the development of exper...
September 11, 2023, 2:44 am
Roche open to big acquisitions 'if it makes scientific and financial sense' - ceo tells newspaper
Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $2...
September 9, 2023, 3:50 pm
Here's why novartis (nvs) is a strong value stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
September 6, 2023, 11:18 am
novartis names new board member after international boss steps down
novartis has appointed AbbVie executive Patrick Horber to its executive committee, the Swiss pharmaceut...
September 6, 2023, 1:40 am